ID   DOC2B_RAT               Reviewed;         412 AA.
AC   P70610;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 2.
DT   24-JUL-2024, entry version 146.
DE   RecName: Full=Double C2-like domain-containing protein beta;
DE            Short=Doc2-beta;
GN   Name=Doc2b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9115738; DOI=10.1016/s0896-6273(00)81245-3;
RA   Verhage M., de Vries K.J., Roeshol H., Burbach J.P., Gispen W.H.,
RA   Suedhof T.C.;
RT   "DOC2 proteins in rat brain: complementary distribution and proposed
RT   function as vesicular adapter proteins in early stages of secretion.";
RL   Neuron 18:453-461(1997).
RN   [2]
RP   INTERACTION WITH DYNLT1.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9804756; DOI=10.1074/jbc.273.46.30065;
RA   Nagano F., Orita S., Sasaki T., Naito A., Sakaguchi G., Maeda M.,
RA   Watanabe T., Kominami E., Uchiyama Y., Takai Y.;
RT   "Interaction of Doc2 with tctex-1, a light chain of cytoplasmic dynein.
RT   Implication in dynein-dependent vesicle transport.";
RL   J. Biol. Chem. 273:30065-30068(1998).
RN   [3]
RP   INTERACTION WITH UNC13A, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   15-GLN--ILE-20.
RX   PubMed=15033971; DOI=10.1074/jbc.m400731200;
RA   Groffen A.J., Brian E.C., Dudok J.J., Kampmeijer J., Toonen R.F.,
RA   Verhage M.;
RT   "Ca(2+)-induced recruitment of the secretory vesicle protein DOC2B to the
RT   target membrane.";
RL   J. Biol. Chem. 279:23740-23747(2004).
RN   [4]
RP   FUNCTION, PHOSPHOLIPID-BINDING, MUTAGENESIS OF ASP-218 AND ASP-220, AND
RP   INTERACTION WITH STX1A AND SNAP25.
RX   PubMed=18596155; DOI=10.1523/jneurosci.0538-08.2008;
RA   Friedrich R., Groffen A.J., Connell E., van Weering J.R., Gutman O.,
RA   Henis Y.I., Davletov B., Ashery U.;
RT   "DOC2B acts as a calcium switch and enhances vesicle fusion.";
RL   J. Neurosci. 28:6794-6806(2008).
RN   [5]
RP   FUNCTION, PHOSPHOLIPID-BINDING, INTERACTION WITH SNARE COMPLEX, AND
RP   MUTAGENESIS OF HIS-158; PHE-222; LYS-237; LYS-319 AND ILE-360.
RX   PubMed=20150444; DOI=10.1126/science.1183765;
RA   Groffen A.J., Martens S., Diez Arazola R., Cornelisse L.N., Lozovaya N.,
RA   de Jong A.P., Goriounova N.A., Habets R.L., Takai Y., Borst J.G., Brose N.,
RA   McMahon H.T., Verhage M.;
RT   "Doc2b is a high-affinity Ca2+ sensor for spontaneous neurotransmitter
RT   release.";
RL   Science 327:1614-1618(2010).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium sensor which positively regulates SNARE-dependent
CC       fusion of vesicles with membranes. Binds phospholipids in a calcium-
CC       dependent manner and may act at the priming stage of fusion by
CC       modifying membrane curvature to stimulate fusion. Involved in calcium-
CC       triggered exocytosis in chromaffin cells and calcium-dependent
CC       spontaneous release of neurotransmitter in absence of action potentials
CC       in neuronal cells. Involved both in glucose-stimulated insulin
CC       secretion in pancreatic cells and insulin-dependent GLUT4 transport to
CC       the plasma membrane in adipocytes. {ECO:0000269|PubMed:18596155,
CC       ECO:0000269|PubMed:20150444}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC   -!- SUBUNIT: Interacts with STX4; the interaction is calcium-dependent,
CC       increased by insulin and glucose, and mediates vesicle fusion with
CC       plasma membrane in pancreatic cells and adipocytes. Interacts with
CC       STXBP3; the interaction is direct, occurs at the cell membrane and
CC       regulates glucose-stimulated insulin secretion (By similarity).
CC       Interacts with cytoplasmic dynein light chain DYNLT1. Interacts with
CC       the SNARE (soluble N-ethylmaleimide-sensitive factor attached protein
CC       receptor) complex composed of SNAP25, STX1A and VAMP2; the interaction
CC       is calcium-dependent and competitive with SYT1. May interact with
CC       UNC13A; the interaction mediates targeting to the plasma membrane.
CC       {ECO:0000250, ECO:0000269|PubMed:15033971, ECO:0000269|PubMed:18596155,
CC       ECO:0000269|PubMed:20150444, ECO:0000269|PubMed:9804756}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic granule {ECO:0000250}.
CC       Cell membrane; Peripheral membrane protein. Note=Translocates to the
CC       plasma membrane in a calcium-dependent manner.
CC   -!- TISSUE SPECIFICITY: Expressed in brain; highly enriched in neurons.
CC       {ECO:0000269|PubMed:9115738}.
CC   -!- DOMAIN: C2 domain 1 is involved in binding calcium and phospholipids.
CC       C2 domain 2 may also play a role in the calcium-dependent targeting to
CC       membranes (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U70778; AAB47747.2; -; mRNA.
DR   RefSeq; NP_112404.1; NM_031142.1.
DR   PDB; 4LCV; X-ray; 2.00 A; A/B/C/D=125-255.
DR   PDB; 4LDC; X-ray; 1.26 A; A=265-412.
DR   PDBsum; 4LCV; -.
DR   PDBsum; 4LDC; -.
DR   AlphaFoldDB; P70610; -.
DR   SMR; P70610; -.
DR   STRING; 10116.ENSRNOP00000074543; -.
DR   iPTMnet; P70610; -.
DR   PhosphoSitePlus; P70610; -.
DR   PaxDb; 10116-ENSRNOP00000008429; -.
DR   ABCD; P70610; 1 sequenced antibody.
DR   GeneID; 81820; -.
DR   KEGG; rno:81820; -.
DR   AGR; RGD:620519; -.
DR   CTD; 8447; -.
DR   RGD; 620519; Doc2b.
DR   eggNOG; KOG1013; Eukaryota.
DR   InParanoid; P70610; -.
DR   OrthoDB; 590187at2759; -.
DR   PhylomeDB; P70610; -.
DR   EvolutionaryTrace; P70610; -.
DR   PRO; PR:P70610; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0098850; C:extrinsic component of synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB.
DR   GO; GO:0019905; F:syntaxin binding; ISO:RGD.
DR   GO; GO:0048791; P:calcium ion-regulated exocytosis of neurotransmitter; IDA:UniProtKB.
DR   GO; GO:0099502; P:calcium-dependent activation of synaptic vesicle fusion; IDA:SynGO.
DR   GO; GO:0006887; P:exocytosis; IEP:RGD.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IDA:UniProtKB.
DR   GO; GO:0008104; P:protein localization; ISS:UniProtKB.
DR   GO; GO:0017158; P:regulation of calcium ion-dependent exocytosis; IBA:GO_Central.
DR   GO; GO:0061669; P:spontaneous neurotransmitter secretion; ISO:RGD.
DR   CDD; cd04035; C2A_Rabphilin_Doc2; 1.
DR   CDD; cd08384; C2B_Rabphilin_Doc2; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR014638; Doc2.
DR   InterPro; IPR043566; Rabphilin/DOC2/Noc2.
DR   InterPro; IPR047022; Rabphilin_Doc2_C2A.
DR   InterPro; IPR001565; Synaptotagmin.
DR   PANTHER; PTHR45729:SF9; DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN BETA; 1.
DR   PANTHER; PTHR45729; RABPHILIN, ISOFORM A; 1.
DR   Pfam; PF00168; C2; 2.
DR   PIRSF; PIRSF036931; Doc2; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00399; SYNAPTOTAGMN.
DR   SMART; SM00239; C2; 2.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   PROSITE; PS50004; C2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Calcium/phospholipid-binding; Cell membrane;
KW   Cytoplasm; Membrane; Metal-binding; Phosphoprotein; Reference proteome;
KW   Repeat.
FT   CHAIN           1..412
FT                   /note="Double C2-like domain-containing protein beta"
FT                   /id="PRO_0000079970"
FT   DOMAIN          126..250
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          266..399
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..90
FT                   /note="Mediates interaction with DYNLT1"
FT                   /evidence="ECO:0000250"
FT   REGION          1..36
FT                   /note="Negatively regulates targeting to plasma membrane"
FT                   /evidence="ECO:0000250"
FT   REGION          38..123
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          257..375
FT                   /note="Mediates interaction with STXBP3"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        43..57
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         157
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         163
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         218
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         220
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         297
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         297
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         303
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         357
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         357
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         359
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         359
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         365
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         15..20
FT                   /note="QEHMAI->YKDWAF: Prevents diacylglycerol-induced
FT                   localization to the plasma membrane. Probably prevents
FT                   interaction with UNC13A."
FT                   /evidence="ECO:0000269|PubMed:15033971"
FT   MUTAGEN         158
FT                   /note="H->A: Loss of calcium-dependent binding to liposomes
FT                   and altered fusion-promoting activity; when associated with
FT                   A-222 and A-360."
FT                   /evidence="ECO:0000269|PubMed:20150444"
FT   MUTAGEN         218
FT                   /note="D->N: Binds liposomes in a calcium-independent
FT                   manner; when associated with N-220."
FT                   /evidence="ECO:0000269|PubMed:18596155"
FT   MUTAGEN         220
FT                   /note="D->N: Binds liposomes in a calcium-independent
FT                   manner; when associated with N-218."
FT                   /evidence="ECO:0000269|PubMed:18596155"
FT   MUTAGEN         222
FT                   /note="F->A: Loss of calcium-dependent binding to liposomes
FT                   and altered fusion-promoting activity; when associated with
FT                   A-158 and A-360."
FT                   /evidence="ECO:0000269|PubMed:20150444"
FT   MUTAGEN         237
FT                   /note="K->E: Loss of calcium-independent binding to
FT                   liposomes. Loss of interaction with the SNARE complex and
FT                   altered fusion-promoting activity; when associated with E-
FT                   319."
FT                   /evidence="ECO:0000269|PubMed:20150444"
FT   MUTAGEN         319
FT                   /note="K->E: Loss of calcium-independent binding to
FT                   liposomes. Loss of interaction with the SNARE complex and
FT                   altered fusion-promoting activity; when associated with E-
FT                   237."
FT                   /evidence="ECO:0000269|PubMed:20150444"
FT   MUTAGEN         360
FT                   /note="I->A: Loss of calcium-dependent binding to liposomes
FT                   and altered fusion-promoting activity; when associated with
FT                   A-158 and A-222."
FT                   /evidence="ECO:0000269|PubMed:20150444"
FT   STRAND          129..137
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   HELIX           138..140
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          142..152
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          164..172
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   HELIX           176..178
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          192..199
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   HELIX           204..209
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          211..218
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          226..234
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   HELIX           235..237
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          244..249
FT                   /evidence="ECO:0007829|PDB:4LCV"
FT   STRAND          266..277
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   TURN            278..281
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          282..292
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          304..312
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          332..340
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   HELIX           343..348
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          350..357
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          360..362
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          365..373
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   HELIX           378..389
FT                   /evidence="ECO:0007829|PDB:4LDC"
FT   STRAND          395..403
FT                   /evidence="ECO:0007829|PDB:4LDC"
SQ   SEQUENCE   412 AA;  45841 MW;  61595BC6886F1012 CRC64;
     MTLRRRGEKA TISIQEHMAI DVCPGPIRPI KQISDYFPRF PRGLPPTAAP RASAPPDAPA
     RSPAATAGPR SPSDGARDDD EDVDQLFGAY GASPGPSPGP SPVRPPAKPP EDEPDADGYE
     SDDCTALGTL DFSLLYDQEN NALHCTISKA KGLKPMDHNG LADPYVKLHL LPGASKANKL
     RTKTLRNTLN PSWNETLTYY GITDEDMIRK TLRISVCDED KFRHNEFIGE TRVPLKKLKP
     NHTKTFSICL EKQLPVDKAE DKSLEERGRI LISLKYSSQK QGLLVGIVRC AHLAAMDANG
     YSDPYVKTYL KPDVDKKSKH KTAVKKKTLN PEFNEEFCYE IKHGDLAKKT LEVTVWDYDI
     GKSNDFIGGV VLGINAKGER LKHWFDCLKN KDKRIERWHT LTNEIPGAVL SD
//
